Nanocomposites and colorectal cancer
Colorectal cancer is the third most common type of cancer worldwide. Incidences of colorectal cancer continue to increase, prompting researchers to explore potential therapies for future treatment.
A recent study, utilising high purity Undaria pinnatifida fucoidan manufactured by Marinova, explored the anti-cancer activity of nanoparticles and bioactive nanocomposites against colorectal cancer cell lines.
The study found the nanocomposite containing the Undaria pinnatifida fucoidan to be the most effectual against CaCo-2 and HT-29 colorectal cancer cell lines, significantly exceeding the action of the standard chemotherapy drug cisplatin. The nanocomposite induced severe apoptosis and deformation signs in the cancer cells, leading researchers to suggest the constituents have potential in the future management of colorectal cancer.
The paper, ‘The anticancer activity of fucoidan coated selenium nanoparticles and curcumin nanoparticles against colorectal cancer lines,’ was published in Scientific Reports.